Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma

British Journal of Dermatology

Volumn 160, Issue 3, 2009, Pages 519-526

  Nieto Rementeria N ^a   Perez Yarza G ^a   Boyano, M D ^a   Apraiz, A ^a   Izu, R ^b   Diaz Perez J L ^c   Asumendi, A ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

Author keywords

Ataxia telangiectasia mutated protein; Bexarotene; Cutaneous T cell lymphoma; Retinoid X receptor; Tumour suppressor protein p53; Tumour suppressor protein p73

Indexed keywords

ATM PROTEIN; BEXAROTENE; CYCLIN DEPENDENT KINASE 1; KI 67 ANTIGEN; METHYLCELLULOSE; PROTEIN BAX; PROTEIN P21; PROTEIN P53; PROTEIN P73; SURVIVIN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL SURVIVAL; DNA-BINDING PROTEINS; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 60449091726     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08931.x     Document Type: Article

References (41)

1. Bagot M. Cutaneous T-cell lymphoma (CTCL): classification, staging, and treatment options. Dermatol Clin 2008 26 (Suppl. 1 3 12.
2. Pichardo DA, Querfeld C, Guitart J et al. Cutaneous T-cell lymphoma: a paradigm for biological therapies. Leuk Lymphoma 2004 45 : 1755 65.
3. Querfeld C, Nagelli LV, Rosen ST et al. Bexarotene in the treatment of cutaneous T-cell lymphoma. Expert Opin Pharmacother 2006 7 : 907 15.
4. Zhang C, Duvic M. Treatment of cutaneous T-cell lymphoma with retinoids. Dermatol Ther 2006 19 : 264 71.
5. Farol LT, Hymes KB. Bexarotene: a clinical review. Expert Rev Anticancer Ther 2004 4 : 180 8.
6. Zhang C, Hazarika P, Ni X et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res 2002 8 : 1234 40.
7. Budgin JB, Richardson SK, Newton SB et al. Biological effects of bexarotene in cutaneous T-cell lymphoma. Arch Dermatol 2005 141 : 315 21.
8. Cheng S, Kupper T. A new rexinoid for cutaneous T-cell lymphoma. Arch Dermatol 2001 137 : 649 52.
9. Nawa T, Nawa MT, Cai Y et al. Repression of TNF-alpha-induced E-selectin expression by PAR activators: involvement of transcriptional repressor LRF-1/ATF3. Biochem Biophys Res Commun 2000 275 : 406 11.
10. No authors listed. Bexarotene: new preparation. Cutaneous lymphoma: too many adverse effects. Prescrire Int 2004 13 : 94 7.
11. Levrero M, De Laurenzi V, Costanzo A et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 2000 113 : 1661 70.
12. Scian MJ, Carchman EH, Mohanraj L et al. Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Oncogene 2008 27 : 2583 93.
13. 2 arrest after DNA damage. Science 1998 282 : 1497 501.
14. Jin Y, Wei Y, Xiong L et al. Differential regulation of survivin by p53 contributes to cell cycle dependent apoptosis. Cell Res 2005 1 : 361 70.
15. Chipuk JE, Kuwana T, Bouchier-Hayes L et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004 13 : 1010 14.
16. Ramadan S, Terrinoni A, Catani MV et al. p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 2005 331 : 713 17.
17. Melino G, Bernassola F, Ranalli M et al. p73 induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 2004 279 : 8076 83.
18. Dey A, Verma CS, Lane DP. Updates on p53: modulation of p53 degradation as a therapeutic approach. Br J Cancer 2008 98 : 4 8.
19. Yoshida K, Liu H, Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 2006 281 : 5734 40.
20. Morales MC, Pérez-Yarza G, Rementería NN et al. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2. Free Radic Res 2007 41 : 591 601.
21. Mikhailov V, Mikhailova M, Pulkrabek DJ et al. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001 276 : 18361 74.
22. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998 17 : 3878 85.
23. Drach J, Gattringer C, Glassl H et al. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma. Cytometry 1989 10 : 743 9.
24. O'Connor DS, Grossman D, Plescia J et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 2000 97 : 13103 7.
25. Shouse GP, Cai X, Liu X. Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A. Mol Cell Biol 2008 28 : 448 56.
26. Derjuga A, Richard C, Crosato M et al. Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cells. J Biol Chem 2000 276 : 37815 20.
27. Zhang X, Li J, Sejas DP et al. The ATM/p53/p21 pathway influences cell fate decision between apoptosis and senescence in reoxygenated hematopoietic progenitor cells. J Biol Chem 2005 280 : 19635 40.
28. Zhang CL, Kamarashev J, Qin JZ et al. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol 2003 200 : 249 54.
29. Altieri DC. Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 2003 5 : 447 52.
30. Krause K, Wasner M, Reinhard W et al. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 2000 28 : 4410 18.
31. Marampon F, Casimiro MC, Fu M et al. Nerve growth factor regulation of cyclin D1 in PC12 cells through a p21RAS ERK-pathway requires cooperative interactions between Sp1 and NF-κB. Mol Biol Cell 2008 19 : 2566 78.
32. Hermann TW, Yen WC, Tooker P et al. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells. Lung Cancer 2005 50 : 9 18.
33. Li Y, Zhang Y, Hill J et al. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice. Br J Cancer 2008 98 : 1380 8.
34. Brennand S, Sutton VR, Biagi J et al. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy. Br J Dermatol 2005 152 : 1199 205.
35. Yoon HS, Yang VW. Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 2004 279 : 5035 41.
36. Zhang J, Tu Y, Smith-Schneider S. Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells. Cancer Cell Int 2005 5 : 6.
37. Boya P, Morales MC, Gonzalez-Polo RA et al. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene 2003 22 : 6220 30.
38. Innocente SA, Lee JM. p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription. Biochem Biophys Res Commun 2005 329 : 713 18.
39. Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990 10 : 5502 9.
40. Lemasson I, Nyborg JK. Human T-cell leukemia virus type I tax repression of p73beta is mediated through competition for the C/H1 domain of CBP. J Biol Chem 2001 276 : 15720 7.
41. Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of Bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology 1997 231 : 135 40.